• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少性传播感染及18岁以下怀孕的一对一干预措施:经济评估的系统评价

One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.

作者信息

Barham L, Lewis D, Latimer N

机构信息

NERA Economic Consulting, 15 Stratford Place, London, UK, W1C 1BE.

出版信息

Sex Transm Infect. 2007 Oct;83(6):441-6. doi: 10.1136/sti.2007.025361. Epub 2007 Jul 11.

DOI:10.1136/sti.2007.025361
PMID:17626115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2598700/
Abstract

OBJECTIVE

To systematically review and critically appraise the economic evaluations of one to one interventions to reduce sexually transmitted infections (STIs) and teenage conceptions.

DESIGN

Systematic review.

DATA SOURCES

Search of four electronic bibliographic databases from 1990 to January 2006. Search keywords included teenage, pregnancy, adolescent, unplanned, unwanted, cost benefit, cost utility, economic evaluation, cost effectiveness and all terms for STIs, including specific diseases.

REVIEW METHODS

We included studies that evaluated a broad range of one to one interventions to reduce STIs. Outcomes included major outcomes averted, life years and quality adjusted life years (QALY). All studies were assessed against quality criteria.

RESULTS

Of 3,190 identified papers, 55 were included. The majority of studies found one to one interventions to be either cost saving or cost effective, although one highlighted the need to target the population to receive post-exposure prophylaxis to reduce transmission of HIV. Most studies used a static approach that ignores the potential re-infection of treated patients.

CONCLUSION

One to one interventions have been shown to be cost saving or cost effective but there are some limitations in applying this evidence to the UK policy context. More UK research using dynamic modelling approaches and QALYs would provide improved evidence, enabling more robust policy recommendations to be made about which one to one interventions are cost effective in reducing STIs in the UK setting. The results of this review can be used by policy makers, health economists and researchers considering further research in this area.

摘要

目的

系统评价并严格评估一对一干预措施在减少性传播感染(STIs)和青少年意外怀孕方面的经济学评价。

设计

系统评价。

数据来源

检索1990年至2006年1月的四个电子文献数据库。检索关键词包括青少年、怀孕、青春期、意外、 unwanted、成本效益、成本效用、经济学评价、成本效果以及所有性传播感染相关术语,包括特定疾病。

综述方法

纳入评估广泛的一对一干预措施以减少性传播感染的研究。结局包括避免的主要结局、生命年和质量调整生命年(QALY)。所有研究均依据质量标准进行评估。

结果

在3190篇检索到的论文中,纳入了55篇。大多数研究发现一对一干预措施具有成本节约或成本效果,尽管有一项研究强调需要针对人群进行暴露后预防以减少艾滋病毒传播。大多数研究采用静态方法,忽略了已治疗患者潜在的再次感染。

结论

一对一干预措施已被证明具有成本节约或成本效果,但在将这一证据应用于英国政策背景方面存在一些局限性。更多采用动态建模方法和QALY的英国研究将提供更好的证据,从而能够就哪些一对一干预措施在英国环境中减少性传播感染方面具有成本效果提出更有力的政策建议。本综述结果可供政策制定者、卫生经济学家和考虑在该领域进一步研究的研究人员使用。

相似文献

1
One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.减少性传播感染及18岁以下怀孕的一对一干预措施:经济评估的系统评价
Sex Transm Infect. 2007 Oct;83(6):441-6. doi: 10.1136/sti.2007.025361. Epub 2007 Jul 11.
2
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
7
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2001(2):CD001220. doi: 10.1002/14651858.CD001220.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.

引用本文的文献

1
Point-of-care diagnostics for sexually transmitted infections among migrants in Greece.希腊移民性传播感染的即时诊断
Public Health Action. 2024 Mar 1;14(1):14-19. doi: 10.5588/pha.23.0022. eCollection 2024 Mar.
2
A Qualitative Study of the Benefits and Utility of Brief Motivational Interviewing to Reduce Sexually Transmitted Infections among Men Who Have Sex with Men.一项关于简短动机性访谈对降低男男性行为者性传播感染的益处和效用的定性研究。
Behav Sci (Basel). 2023 Aug 4;13(8):654. doi: 10.3390/bs13080654.
3
The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.高收入国家集中流行地区艾滋病毒/性传播感染预防的成本效益:范围综述。
AIDS Behav. 2022 Jul;26(7):2279-2298. doi: 10.1007/s10461-022-03583-y. Epub 2022 Jan 15.
4
Opt-out Testing Pilot for Sexually Transmitted Infections Among Immigrant Detainees at 2 Immigration and Customs Enforcement Health Service Corps-Staffed Detention Facilities, 2018.2018年在2个由移民和海关执法局卫生服务团配备人员的拘留设施中对移民拘留者进行性传播感染的退出式检测试点。
Public Health Rep. 2020 Jul/Aug;135(1_suppl):82S-89S. doi: 10.1177/0033354920928491.
5
A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.以色列到2025年减轻性传播感染负担的国家战略计划。
Isr J Health Policy Res. 2017 Apr 19;6:23. doi: 10.1186/s13584-017-0141-8. eCollection 2017.
6
The economic impact of project MARS (motivating adolescents to reduce sexual risk).项目 MARS(激励青少年减少性风险)的经济影响。
Health Psychol. 2013 Sep;32(9):1003-12. doi: 10.1037/a0033607.
7
An economic model of school-based behavioral interventions to prevent sexually transmitted infections.基于学校的行为干预措施预防性传播感染的经济模型。
Int J Technol Assess Health Care. 2012 Oct;28(4):407-14. doi: 10.1017/S0266462312000475. Epub 2012 Sep 21.
8
Cost effectiveness of one to one STI prevention interventions.一对一性传播感染预防干预措施的成本效益
Sex Transm Infect. 2007 Oct;83(6):423-4. doi: 10.1136/sti.2007.026641.

本文引用的文献

1
Noninvasive screening for genital chlamydial infections in asymptomatic men: Strategies and costs using a urine PCR assay.无症状男性生殖器衣原体感染的非侵入性筛查:使用尿液PCR检测的策略与成本
Can J Infect Dis. 1998 Sep;9(5):281-6. doi: 10.1155/1998/286027.
2
Cost-effectiveness of screening for genital Chlamydia trachomatis.筛查生殖道沙眼衣原体的成本效益。
Expert Rev Pharmacoecon Outcomes Res. 2001 Dec;1(2):145-56. doi: 10.1586/14737167.1.2.145.
3
Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.沙眼衣原体筛查:经济评估与建模的系统评价
Sex Transm Infect. 2006 Jun;82(3):193-200; discussion 201. doi: 10.1136/sti.2005.017517.
4
Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.模拟机会性筛查对澳大利亚女性沙眼衣原体感染后遗症及公共医疗成本的影响。
Public Health. 2006 Jan;120(1):42-9. doi: 10.1016/j.puhe.2005.03.002. Epub 2005 Nov 2.
5
A cost-effectiveness analysis of interventions to increase repeat testing in patients treated for gonorrhea or chlamydia at public sexually transmitted disease clinics.在公共性传播疾病诊所对接受淋病或衣原体治疗的患者增加重复检测干预措施的成本效益分析。
Sex Transm Dis. 2005 Sep;32(9):542-9. doi: 10.1097/01.olq.0000175414.80023.59.
6
Costs and effects of chlamydial screening: dynamic versus static modeling.衣原体筛查的成本与效果:动态模型与静态模型对比
Sex Transm Dis. 2005 Aug;32(8):474-83. doi: 10.1097/01.olq.0000161181.48687.cf.
7
Expanded screening for HIV in the United States--an analysis of cost-effectiveness.美国扩大HIV筛查——成本效益分析
N Engl J Med. 2005 Feb 10;352(6):586-95. doi: 10.1056/NEJMsa042088.
8
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代的HIV筛查成本效益
N Engl J Med. 2005 Feb 10;352(6):570-85. doi: 10.1056/NEJMsa042657.
9
Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
Int J STD AIDS. 2004 Dec;15(12):797-802. doi: 10.1258/0956462042563765.
10
An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.对英国苏格兰产前、堕胎、阴道镜检查及计划生育诊所就诊女性进行沙眼衣原体感染筛查的经济学评估及可接受性评估。
BJOG. 2004 Nov;111(11):1261-8. doi: 10.1111/j.1471-0528.2004.00324.x.